Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 8/12/16 → 6/30/18 |
Funding
- Celgene: $17,262.00
A Phase 3, Randomized, Double Blind Placebo Controlled Multicenter Study to Investigate the Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Subjects with Active Crohn's Disease
- Flomenhoft, Deborah (PI)
- Leyson, Christina (CoI)